Skip to content

Surgical Prevention of Anastomotic Recurrence by Excluding Mesentery in Crohn's Disease

A New Anastomotic Technique After Ileocecal Resection for Crohn's Disease. Kono-s Anastomosis vs Stapled Side-to-side Anastomosis: a Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02631967
Acronym
SuPREMeCD
Enrollment
132
Registered
2015-12-16
Start date
2015-11-30
Completion date
2022-11-30
Last updated
2017-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn Disease

Keywords

Crohn disease, ileocecal resection, anastomosis, Kono

Brief summary

Kono and collegues have described a new anastomotic technique to restore bowel contintuity after ileocecal resection for Crohn's disease (CD). This tecnique implies a hand-sewn ileocolic anastomosis, that involves exclusively the antimesenteric side of the bowel and that functionally acts as an end-to-end anastomosis. In a retrospective study, the authors have shown that this anastomotic tecnique, when compared to stapled side-to-side anastomosis, significantly reduces the severity of endoscopic recurrence at 1 year after surgery and the rate of reoperation for anastomotic recurrence at 5 years after surgery. Aim of this trial is to compare the outcomes of the Kono anastomosis with the ones achieved by the stapled side-to-side anastomosis, within a prospective randomized study.

Interventions

PROCEDUREKono anastomosis

Kono anastomosis

Stapled side-to-side anastomosis

Sponsors

Federico II University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Patients with Crohn's disease requiring ileocecal resection

Exclusion criteria

* age \> 75 years * age \< 18 years * inability to give the consent to the participation in the trial * refusal to participate in the trial after receiving accurate information

Design outcomes

Primary

MeasureTime frameDescription
Grade of endoscopic recurrence6 MonthsSeverity of endoscopic recurrence (graded according to Rutgeerts' score) at the site of anastomosis at 6 months after surgery.
Surgical recurrenceUp to 5 yearsRate of patients requiring resection for anastomotic recurrence within 5 years after surgery

Secondary

MeasureTime frameDescription
Grade of endoscopic recurrence6 months up to 5 yearsSeverity of endoscopic recurrence at the site of anastomosis
Clinical recurrenceUp to 5 yearsPresence of clinical recurrence (according to Crohn's disease activity index)
Operating timeIntraoperativelyDuration of the operation (min)
Surgical re-interventionUp to 30 daysRate of patients requiring surgical re-intervention
Anastomotic leakUp to 30 daysIncidence of anastomotic leak
Postoperative morbidity rateUp to 30 daysPostoperative surgical (bleeding, obstruction, postoperative ileus, abdominal collection, wound infection) and medical morbidity as well as mortality will be documented and graded according to the Dindo Clavien classification
Recovery timesParticipants will be followed for the duration of hospital stay, an expected average of 5 daysLength of post-operative hospital stay, time to first flatus, time to first defecation, time to tolerance of liquid and solid diet will be documented
Anastomosis timeIntraoperativelyTime (min) required to perform the anastomosis
Endoscopic recurrence6 months up to 5 yearsPresence of endoscopic recurrence

Countries

Italy

Contacts

Primary ContactLuigi Bucci, Prof
luigi.bucci@unina.it00390817462850

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026